129 related articles for article (PubMed ID: 17053174)
1. Assessment of a serum assay for quantification of abdominal aortic calcification.
Clancy P; Oliver L; Jayalath R; Buttner P; Golledge J
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2574-6. PubMed ID: 17053174
[No Abstract] [Full Text] [Related]
2. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
[TBL] [Abstract][Full Text] [Related]
3. Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis.
Bezerra MC; Calomeni GD; Caparbo VF; Gebrim ES; Rocha MS; Pereira RM
Rheumatology (Oxford); 2005 Dec; 44(12):1503-6. PubMed ID: 16219645
[TBL] [Abstract][Full Text] [Related]
4. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.
Rhee EJ; Oh KW; Jung CH; Lee WY; Oh ES; Yun EJ; Baek KH; Kang MI; Kim SW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):689-97. PubMed ID: 16712673
[TBL] [Abstract][Full Text] [Related]
5. Correspondence re: A. Lipton et al., Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002.
Dovio A; Sartori ML; Angeli A
Clin Cancer Res; 2003 Jun; 9(6):2384-5; author reply 2386. PubMed ID: 12796409
[No Abstract] [Full Text] [Related]
6. Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.
Depil S; Mathiot C; Leleu X; Moreau AS; Faucompré JL; Hennache B; Bauters F; Bataille R; Facon T
Br J Haematol; 2005 Jun; 129(5):706-7. PubMed ID: 15916694
[No Abstract] [Full Text] [Related]
7. Skeleton key to vascular disease.
Demer LL; Abedin M
J Am Coll Cardiol; 2004 Nov; 44(10):1977-9. PubMed ID: 15542279
[No Abstract] [Full Text] [Related]
8. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Nitta K; Akiba T; Uchida K; Kawashima A; Yumura W; Kabaya T; Nihei H
Am J Kidney Dis; 2003 Aug; 42(2):303-9. PubMed ID: 12900812
[TBL] [Abstract][Full Text] [Related]
9. French women, fractures and aortic calcifications.
Rajzbaum G; Roger VL; Bézie Y; Chauffert M; Bréville P; Roux F; Safar ME; Blacher J
J Intern Med; 2005 Jan; 257(1):117-9. PubMed ID: 15606383
[No Abstract] [Full Text] [Related]
10. Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes.
Shin JY; Shin YG; Chung CH
Diabetes Care; 2006 Jul; 29(7):1664-6. PubMed ID: 16801598
[No Abstract] [Full Text] [Related]
11. [Osteoprotegerin (OPG)].
Takahashi N; Kimura H; Yoshida H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():818-20. PubMed ID: 16149650
[No Abstract] [Full Text] [Related]
12. Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al.
Golmia RP; Sousa BD; Scheinberg MA
Arthritis Rheum; 2002 Dec; 46(12):3390-1; author reply 3392. PubMed ID: 12483748
[No Abstract] [Full Text] [Related]
13. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
Vegni FE; Corradini C; Privitera G
N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14711922
[No Abstract] [Full Text] [Related]
14. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.
Price PA; Williamson MK; Nguyen TM; Than TN
J Biol Chem; 2004 Jan; 279(3):1594-600. PubMed ID: 14578360
[TBL] [Abstract][Full Text] [Related]
15. ELISA methodology for detection of modified osteoprotegerin in clinical studies.
Chen D; Sarikaya NA; Gunn H; Martin SW; Young JD
Clin Chem; 2001 Apr; 47(4):747-9. PubMed ID: 11274028
[No Abstract] [Full Text] [Related]
16. No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism.
Nishi H; Nii-Kono T; Ikeda K; Fujimori A; Fukagawa M
Clin Nephrol; 2006 Feb; 65(2):149-50. PubMed ID: 16509469
[No Abstract] [Full Text] [Related]
17. [A study on serum glycoprotein in arteriosclerosis with special reference to diabetes mellitus, hypertension and aortic arch calcification -- an examination by gel chromatography and cellulose acetate electrophoresis (author's transl)].
Izumiyama S
Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):577-86. PubMed ID: 7206296
[No Abstract] [Full Text] [Related]
18. [Risk factors of atherosclerosis in end-stage renal disease patients].
Jono S
Clin Calcium; 2004 Jan; 14(1):21-6. PubMed ID: 15576949
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Shahapuni I; Esper NE; Opisiv R; Massy Z; Choukroun G; Garabedian M; Fournier A
Nephrol Dial Transplant; 2008 Apr; 23(4):1456-7; author reply 1457-8. PubMed ID: 18039645
[No Abstract] [Full Text] [Related]
20. Pitting phosphate transport inhibitors against vascular calcification.
Demer LL; Tintut Y
Circ Res; 2006 Apr; 98(7):857-9. PubMed ID: 16614308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
